Kura Oncology (KURA) Return on Capital Employed (QoQ) (2011 - 2026)
Kura Oncology (KURA) Return on Capital Employed (QoQ) (2011 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
| 10 |
Kura Oncology |
802.81 Mn |
802.81 Mn |
18.00 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
-234.00 |
| Dec 31, 2025 |
3,947.00 |
| Sep 30, 2025 |
-736.00 |
| Jun 30, 2025 |
-513.00 |
| Mar 31, 2025 |
342.00 |
| Dec 31, 2024 |
213.00 |
| Sep 30, 2024 |
-1,376.00 |
| Jun 30, 2024 |
-940.00 |
| Mar 31, 2013 |
-82.00 |
| Dec 31, 2012 |
-244.00 |
| Sep 30, 2012 |
-370.00 |
| Jun 30, 2012 |
148.00 |
| Mar 31, 2012 |
-697.00 |
| Dec 31, 2011 |
-458.00 |
| Sep 30, 2011 |
239.00 |
